Home/Filings/4/0000950170-23-064799
4//SEC Filing

THOMA BRAVO FUND X, L.P. 4

Accession 0000950170-23-064799

CIK 0001773383other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 4:05 PM ET

Size

24.0 KB

Accession

0000950170-23-064799

Insider Transaction Report

Form 4
Period: 2023-11-15
Transactions
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2023-11-15$50.00/sh10,000,000$500,000,00031,857,273 total(indirect: See footnote)
  • Other

    Common Stock

    2023-11-152,576,13731,857,273 total(indirect: See footnote)
Footnotes (3)
  • [F1]After giving effect to the distribution reported on this statement, consists of 3,239,632 shares held directly by Thoma Bravo Fund X, L.P. ("TB Fund X"), 694,491 shares held directly by Thoma Bravo Fund X-A, L.P. ("TB Fund X-A"), 15,250,396 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 7,482,290 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 329,933 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund"), 273,513 shares held directly by Thoma Bravo Special Opportunities Fund I, L.P. ("TB SOF"), 2,010,881 shares held directly by Thoma Bravo Special Opportunities Fund I AIV, L.P. ("TB SOF AIV"), 545,546 shares held directly by Thoma Bravo Partners X, L.P. ("TB Partners X"), and 2,030,591 shares held directly by Thoma Bravo Partners XI, L.P. ("TB Partners XI").
  • [F2]TB Partners X is the general partner of each of TB Fund X, TB Fund X-A, TB SOF and TB SOF AIV. TB Partners XI is the general partner of each of TB Fund XI, TB Fund XI-A and TB Exec Fund. Thoma Bravo UGP, LLC is the ultimate managing member of TB Partners X and TB Partners XI. By virtue of the relationships described in this footnote, Thoma Bravo UGP, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A, TB Exec Fund, TB Partners X and TB Partners XI. Each of TB Partners X, TB Partners XI and Thoma Bravo UGP, LLC disclaims beneficial ownership of the shares owned by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund except to the extent of its pecuniary interest therein.
  • [F3]Represents a distribution of (i) 159,600 shares held directly by TB SOF AIV, 22,217 shares held directly by TB SOF, 309,847 shares held directly by TB Fund X and 53,882 shares held directly by TB Fund X-A, in each case to TB Partners X, and (ii) 25,609 shares held directly by TB Exec Fund, 1,450,201 shares held directly by TB Fund XI, and 554,781 shares held directly by TB Fund XI-A, in each case to TB Partners XI.

Documents

1 file

Issuer

Dynatrace, Inc.

CIK 0001773383

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001537211

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:05 PM ET
Size
24.0 KB